Center for Cancer Care & Research

Lakeland, Florida 33805

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant

Studies at this site

• Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients — Completed
• Non-small Cell Lung Cancer Registry — Completed